VJOncology is committed to improving our service to you

VJVirtual | Prognostic value of the SPOP mutant genomic subclass in prostate cancer

VJOncology is committed to improving our service to you

Eric Klein

Eric Klein, MD, Glickman Urology & Kidney Institute, Cleveland, OH, reviews a publication he co-authored on the prognostic value of SPOP mutant genomic subclass in prostate cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter